HR Execs on the Move

WCG Clinical Services

www.wcgclinical.com

 
WCG is the world`s largest and most trusted provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG`s solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials. WCG is proud to serve the individuals on the frontlines of science and medicine, and the ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.wcgclinical.com
  • 212 Carnegie Center Suite 301
    Princeton, NJ USA 08540
  • Phone: 609.945.0101

Executives

Name Title Contact Details
Terri Fleener
Director Talent Acquisition Profile
James Wilkerson
Vice President, Marketing Profile
Melissa Bren
Associate Director, Client Care Profile
David Vogel
Vice President, Digital Marketing and Marketing Operations Profile

Similar Companies

Citadel Technologies

Citadel Technologies is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gala Therapeutics

Gala Therapeutics is a medical devices company developing therapies to improve survival, quality of life, and outcomes for patients with pulmonary diseases.

Algos Preclinical Services

Algos Preclinical Services is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tilray

Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in twelve countries spanning five continents.

Checkmate Pharmaceuticals

Checkmate Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat cancer. Checkmate`s product candidate, CMP-001, is an advanced generation TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body`s innate immune system to attack tumors in combination with other therapies.